Skip to main content
Header image

Řezníčková Eva

Journals

Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines. Investigational New Drugs. 2023, 41(2), 210-219, ISSN: 0167-6997, PMID: 36913160,  PDF.
TOMANOVÁ, M., K. KOZLANSKA, R. JORDA, L. JEDINÁK, T. HAVLIKOVA, E. ŘEZNÍČKOVÁ, M. PERINA, P. KLENER, A. DOLNÍKOVÁ, P. CANKAŘ, V. KRYŠTOF
Synthesis and Structural Optimization of 2,7,9-Trisubstituted purin-8-ones as FLT3-ITD Inhibitors. International Journal of Molecular Sciences. 2022, 23(24), 16169, ISSN: 1422-0067, PMID: 36555810,  PDF.
ŘEZNÍČKOVÁ, E., S. KRAJČOVIČOVÁ, M. PERINA, A. KOVALOVA, M. SOURAL, V. KRYŠTOF
Modulation of FLT3-ITD and CDK9 in acute myeloid leukaemia cells by novel proteolysis targeting chimera (PROTAC). European Journal of Medicinal Chemistry. 2022, 243, 114792, ISSN: 0223-5234, PMID: 36191408,  PDF.